Sally Wynn

Sally Wynn has a wealth of experience in the healthcare and pharmaceutical industry. Sally has worked at Atlas Clinical Research since 2023 as the Senior Vice President of Portfolio Delivery Operations, where they focus on improving patients' lives by bridging them to new treatments. Prior to that, they served as the Head of Study Operationalization at Takeda from 2022 to 2023.

Sally's extensive career at Novartis spanned from 2005 to 2022, during which they held various roles including Global Head Monitoring Excellence, Global Head of Process Control - Trial Monitoring, and Senior Process Control Manager. Sally was also responsible for Trial Operations and Trial Monitoring Quality Management.

Before their time at Novartis, Sally worked at St. Joseph's Children's Hospital of Tampa as a Pediatric Oncology Research Nurse and as a Registered Nurse from 1999 to 2005.

Overall, Sally has demonstrated their expertise and dedication in clinical research, trial monitoring, and healthcare.

Sally Wynn has a Master of Business Administration (MBA) degree with a focus on Business Administration and Management from the University of Florida. Sally also holds a Bachelor of Science (B.S.) degree in Registered Nursing/Registered Nurse from the University of South Florida. In addition, they have obtained certifications including Project Management Professional (PMP) from the Project Management Institute in 2022 and Certified Clinical Research Professional (CCRP) from the Society of Clinical Research Associates (SOCRA) in 2007.